help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Le, W.-W.
Right arrow Articles by Hoffman, G. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Le, W.-W.
Right arrow Articles by Hoffman, G. E.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Seniors' Health
Endocrinology Vol. 142, No. 11 4976-4982
Copyright © 2001 by The Endocrine Society


ARTICLES

Parallel Declines in Fos Activation of the Medial Anteroventral Periventricular Nucleus and LHRH Neurons in Middle-Aged Rats

W.-W. Le, P. M. Wise, A. Z. Murphy, L. M. Coolen and G. E. Hoffman

Department of Anatomy and Neurobiology (W.-W.L., A.Z.M., G.E.H.), University of Maryland, Baltimore, Maryland 21201; Department of Physiology (P.M.W.), University of Kentucky, Lexington, Kentucky 40536; and Department of Cell Biology (L.C.), Neurobiology and Anatomy, University of Cincinnati, Cincinnati, Ohio 45267

Address all correspondence and requests for reprints to: Dr. G. E. Hoffman, Department of Anatomy and Neurobiology, HSF 222, University of Maryland, School of Medicine, 685 West Baltimore Street, Baltimore, Maryland 21201. E-mail: gehoffma{at}umaryland.edu


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The middle-age decline in reproductive function is manifested by reduced LHRH release, resulting in a decreased magnitude and delay of onset of the LH surge. Earlier studies suggested that the reductions in LHRH neural activation in middle-aged rats resulted from deficits in the afferent drive to the LHRH neurons. One critical afferent to the LHRH neurons lies in the anteroventral periventricular preoptic area (AVPv) nucleus. The neurons of the medial AVPv are synchronously activated to express Fos with LHRH neurons at the time of an LH surge in young adult animals. The present study examined whether, in middle age, reductions in the activation of AVPv neurons accompany the reduction in Fos activation in LHRH neurons.

Young (3- to 4-month-old) and middle-aged (10- to 12-month-old) spontaneously cycling and ovariectomized steroid-replaced rats were killed during peak and early descending phase of the LH surge, and their brains were examined for Fos in LHRH and AVPv neurons. Young animals had a characteristic increase in Fos expression in both LHRH and AVPv neurons. In middle-aged rats, the proportion of LHRH neurons expressing Fos at the time of an LH surge was reduced by approximately 50%, irrespective of whether surges were spontaneous or induced by exogenous steroids. A similar reduction in the number of Fos+ cells (by approximately 50%) was noted in the medial AVPv. Linear regression analysis of the relationship between the extent of Fos activation in LHRH and AVPv neurons revealed a strong positive correlation (r2 = 0.66; P < 0.01), suggesting that changes in the AVPv’s drive to LHRH neurons underlie the decrease in LHRH activity in middle age.

A second series of experiments examined whether decreased input from the AVPv could account for reduced Fos activation in LHRH neurons seen in middle-aged animals. When the medial AVPv was lesioned, LHRH neurons failed to express Fos on the side ipsilateral to the lesion. Animals with lesioned medial AVPv also had significantly lower LH values than animals with an intact medial AVPv. Taken together, these data suggest that a principal deficit in middle-aged rats is the ability of the medial AVPv to stimulate LHRH neurons.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
REPRODUCTIVE FUNCTION DECLINES in female rats as middle age approaches. In the early phases of the decline, preovulatory and steroid-induced LH surges are reduced in magnitude and delayed in time onset (1, 2, 3, 4). Reduced LHRH release (5, 6) accompanies the decline in the magnitude of steroid-induced LH surges, and this lowering of LHRH activity is reflected by a decrease in the number of LHRH neurons that express Fos (7, 8, 9) and Jun (9) [markers of cell stimulation (10)]. On the other hand, the number of LHRH neurons and the content of LHRH in the medial basal hypothalamus do not change until long after the reproductive senescence is established (3, 11, 12), suggesting that the deficit during the middle-age period lies in the afferent pathway(s) that regulates LHRH synthesis and/or secretion.

Neurons of the medial-most anteroventral periventricular preoptic area (AVPv) play a critical role in the stimulation of LHRH neurons at the time of the LH surge. The AVPv has had a number of names, making the integration of earlier studies difficult. Bleier (13) initially termed the area the periventricular preoptic area; and our initial studies of this area used the variant pePOA to designate the region (14, 15, 16, 17). Studies from Terasawa’s group (18, 19, 20) had termed this area the medial preoptic nucleus; but currently, a more caudal preoptic nucleus has adopted that name. Irrespective of its name, this region is located along the rostral half of the preoptic area along the ventricular surface in a strip of tissue approximately 70-µm wide and 300- to 400-µm long. The neurons of this medial AVPv innervate the LHRH neurons (21, 22) and are coordinately activated with LHRH neurons at the time of LH surges (14, 15). Lesions of the AVPv with no concomitant loss of LHRH neurons or their axons in the median eminence (23) block both spontaneous LH surges and surges evoked by exogenous E and progesterone (P) in ovariectomized rats (18, 19, 20, 24). These features suggest that a decline in afferent drive from AVPv neurons may account for the attenuation of LHRH activation in middle-aged rats. In the present study, we designed experiments to determine whether changes in the degree of Fos activation within the medial AVPv correlated with changes in LHRH neurons in young and middle-aged rats. A second set of experiments assessed whether elimination of the input from the medial AVPv neurons could mimic the reductions in LHRH Fos activation and LH secretion seen in middle age.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Animals
All protocols were approved by the University Committee on Animal Care and Use at the University of Pittsburgh, where the studies began, and at the Universities of Maryland and Kentucky, where the studies were completed.

Adult female Sprague Dawley rats that were young (3–4 months of age) or middle-aged (10–12 months) were housed under standard laboratory conditions on a 14-h light, 10-h dark schedule. One group of rats (n = 8 young, and n = 8 middle-aged rats) was ovariectomized and, 1 wk later, administered 17ß E2 at 5 h after lights on (180 µg/ml in sesame oil placed into SILASTIC brand capsules (Dow Corning, Midland, MI), 30 mm in length for young or 40 mm for middle-aged rats; capsules had an inner diameter of 0.062 inches and an outer diameter of 0.125 inches). Two days later, P (1.5 mg in 0.2 ml sesame oil) was injected sc to induce an LH surge. Rats were killed on the day of the expected LH surge, either near the peak of the LH surge (11 h after lights on; n = 4) or during the descending limb of the surge (13 h after lights on; n = 4). To determine whether the relationship extended to animals with spontaneous LH surges, we reanalyzed the AVPv and LHRH cells from sections generated in our earlier study (9). This group of rats (n = 5 young; n = 4 middle-aged) was monitored with daily vaginal smears to establish regular estrous cyclicity. Each rat chosen for study demonstrated consecutive 4-d cycles. Rats were killed on proestrus at the same times indicated for the E2 plus P (E+P) groups (11 and 13 h after lights on).

To assess the role of the medial AVPv in LH surge generation and activation of LHRH neurons, 49 ovariectomized young adult rats were anesthetized with chloral hydrate and placed into a stereotaxic apparatus, and 100–200 nl of a 3% solution of ibotenic acid (Sigma, St. Louis, MO; n = 41) or an electrolytic lesion (250–300 µA, 60 sec, n = 5) was directed toward the medial-most AVPv. After a 1- to 2-wk recovery, each animal received an sc injection of 5 µg E, 5 h after lights on. Twenty-four hours later, the rat received 50 µg E (Sigma, in 0.2 ml sesame oil, sc). The next day, at 6 h after lights on, each rat received 5 mg P (0.2 ml in sesame oil, sc). This protocol gives identical timing and amplitudes of LH surges as are found using SILASTIC-E capsules. All animals were killed on the day of P treatment, between 11 and 12 h after lights on (at the time of the induced LH surge in controls).

Preparation of tissue for histology
Ten to 15 min before death, all animals were anesthetized with an overdose of pentobarbital (100 mg/kg), treated with heparin (1000 U), and perfused transcardially with saline containing 2% sodium nitrite followed by 4% paraformaldehyde containing 2.5% acrolein (25, 26). After a second saline flush, each animal’s brain was removed, sunk in aqueous 25% sucrose, and sectioned on a freezing microtome at 25 µm. Twelve sets of serial sections were stored in cryoprotectant antifreeze solution (27) until immunocytochemistry for Fos and LHRH was initiated.

Immunocytochemistry of Fos and LHRH
Immunocytochemical procedures were conducted as described previously (25, 28, 29, 30, 31, 32, 33). Briefly, sections were rinsed free of the cryoprotectant antifreeze solution, in potassium PBS (KPBS, 0.05 M, pH 7.4), reacted with 1% sodium borohydride in KPBS, rinsed, and incubated for 48 h at 4 C in anti-Fos serum from Dr. Philip Larsen (Panum Institute, Denmark) (serum 94012, 1:100,000), Oncogene Science, Inc. (Cambridge, MA) (Ab 4191, 1:400,000), or from Cambridge Research Laboratories (Valley Stream, NY; Ab 0A11-821, 1:40,000). All gave identical results. The diluent for the serum contained 0.3% Triton X-100 in KPBS. The sections were rinsed and incubated in biotinylated secondary antibodies, either antirabbit (when used with antibodies from Dr. Larsen and Oncogene Science, Inc.) or antisheep (when used with antibody from Cambridge Research Laboratories) IgG (heavy and light chains, 1:600 in PBS-Triton-X 100; Vector Laboratories, Inc., Burlingame, CA) for 1 h at room temperature. Sections were again rinsed and incubated for 1 h at room temperature in avidin-biotin complex (45 µl each of A and B Elite reagents/ml KPBS-Triton-X 100; Vector Laboratories, Inc.). After rinses in KPBS and then 0.175 M sodium acetate solution, the sections were stained in a nickel sulfate (25 mg/ml)diaminobenzidine-HCl (DAB, 0.2 mg/ml) in sodium acetate solution containing 0.83 µl 3% H2O2, rinsed in acetate solution, and transferred to KPBS. The sequence of reactions was then repeated, substituting the primary antibody for LHRH. The LHRH antiserum was a polyclonal antibody (gift of Drs. Robert Benoit and Roger Guillemin, Salk Institute, La Jolla, CA), used at a concentration of 1:100,000. The tissue was incubated in antirabbit IgG antiserum (heavy and light chains; Vector Laboratories, Inc. 1:600) rinsed, and reacted with the avidin biotin complex described above. The staining of the peroxidase reaction for LHRH was accomplished with a standard diaminobenzidine solution to yield a brown stain. The staining of Fos is carried to completion by visually monitoring the staining reaction until no further labeling is observed (approximately 15 min). In so doing, the deposited nickel DAB prevents any possibility of erroneous labeling of unstained Fos when the LHRH staining series is run. Fos is entirely nuclear and is never found in the cytoplasm. Moreover, LHRH staining is always found in the cytoplasm. When staining is properly monitored, no nuclear-only brown staining is observed that would confound the results. Preabsorption of the anti-Fos antibody with synthetic Fos (10 µg/ml diluted serum; Peninsula Laboratories Inc., Belmont, CA) yields no nuclear Fos staining. Preabsorption of the LHRH antibody with synthetic LHRH (Abbott Laboratories, Abbott Park, IL; 0.5–1 µg/ml diluted serum) similarly blocks all staining of LHRH-containing structures.

In animals that received lesions, one series of sections was stained for neuron nuclear antigen (NeuN) using a mouse monoclonal antibody (Chemicon) at a concentration of 1:50,000. Standard immunoperoxidase procedures, using nickel DAB as the chromogen (as described above), were followed.

Data analysis
AVPv/Fos. Sections from a 1-in-12 series, from each animal stained with the double peroxidase method, were coded and counted by an observer who was blind to the treatment of the animals. Three sections from each animal, spaced 150 microns apart within the AVPv extending from within 50 µm caudal to the organum vasculosum of the lamina terminalis (OVLT) and extending caudally approximately 400 µm, were chosen for analysis. Using a Nikon (Columbia, MD) Optiphot microscope and a 10x objective (with a 10x eyepiece), the observer scored each Fos-positive cell within a distance 70 µm from the ventricular surface (determined by using an eyepiece grid). This region was chosen for analysis because earlier studies determined that Fos induction at the time of an LH surge was restricted to that narrow AVPv zone (14). More lateral regions within AVPv were not counted because they do not show any changes in Fos expression at the time of the LH surge; this was also true of other subnuclei within the preoptic area. Generally, the areas outside of the medial AVPv show minimal Fos activation at any time during the cycle. Representative rostral-caudal levels through this region are illustrated in Fig. 1Go. The boxes depicted on the right side of the figure show the number, positions, and size of grid boxes in which Fos+ nuclei were counted. A Mann-Whitney U test was used to compare values from the young and old groups; differences were considered significant at the level of P <= 0.05.



View larger version (56K):
[in this window]
[in a new window]
 
Figure 1. Diagrams and micrographs of sections in three rostral-to-caudal levels through the AVPv. In the diagrams, the borders of the AVPv are indicated on the left. The boxes drawn on the right side show the placement of the 70-micron2 eyepiece grid boxes used to count the Fos-positive cells. In the micrographs, the left side shows a Nissl section; the right side is an adjacent section stained for Fos. Levels A–C are 150 µm apart. A, Approximately 75 µm from the organum vasculosum of the lamina terminalis; B, approximately 225 µm from OVLT; C, approximately 375 µm from OVLT. Bar, 100 µm; V3, third ventricle; OC, optic chiasm.

 
LHRH/Fos. Analysis of the proportion of the LHRH neurons that expressed Fos followed the procedure of Le et al. (34). All stained LHRH neurons with a visible nucleus in a 1-in-12 series of sections were analyzed for each animal. The person counting cells was blind to the treatment of the rats. Each LHRH cell throughout the entire forebrain was counted and scored for the presence of cFos, under the light microscope at a magnification of x200 or x400. The data are expressed as the per cent of LHRH neurons that were Fos+. A Mann-Whitney U test was used to determine whether the young and old groups were significantly different. Differences were considered significant at the level of P <= 0.05.

Correlation between AVPv and LHRH Fos activation. The relationship between the number of medial AVPv Fos+ neurons and the proportion of LHRH neurons that expressed Fos was determined with a Spearman Rho nonparametric correlation analysis; P < 0.05 was considered significant.

Analysis of lesion data. Initial histological examination of sections stained with NeuN was used to determine which animals had AVPv lesions. Next, patterns of Fos activation in LHRH neurons from animals with lesioned medial AVPv were compared with those in which the medial AVPv was intact. To determine whether lesions of the medial AVPv reduced secretion of LH, the animals were divided into three groups based on the integrity of the medial AVPv: 1) animals with no detectable lesion in the brain (n = 21) and animals with missed lesions (n = 21); 2) animals with partial medial AVPv lesions (n = 3); and 3) animals with complete unilateral lesions of the medial AVPv (n = 4). Plasma LH values were compared using nonparametric Mann-Whitney U tests.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Consistent with earlier studies, in both cycling rats and steroid-treated ovariectomized young rats, approximately half of the LHRH neurons expressed Fos at the time of the LH, irrespective of whether the surge was spontaneous (mean 49.9% ± 2.2 SEM) or induced by exogenous steroids (mean 46.4% ± 2.4). As shown in Fig. 2AGo, the increase in Fos activation in LHRH neurons seen in young animals was significantly reduced in the middle-aged animals (23.8% ± 2.7 for the E+P group, and 20.8% ± 9.5 for cycling rats). On average, Fos activation in LHRH neurons accompanying the LH surge in young rats was just over twice that observed in middle-aged animals, irrespective of the manner in which the LH surge was generated. No differences between animals killed at the peak of LH secretion and those killed during the early phase of the descending limb of the LH surge was noted. Within AVPv (Fig. 2BGo), Fos activation in the middle-aged animals was also greatly reduced at the time of the LH surge (from 296.8 ± 40.4 to 116.3 ± 40.8 for proestrous rats and from 270.8 ± 23.0 to 132.1 ± 15.8 for ovariectomized steroid-replaced rats). Comparisons between the proportion of LHRH neurons that expressed Fos and the number of Fos+ medial AVPv neurons for both young and middle-aged animals revealed a striking positive correlation (Fig. 3Go, r2 = 0.66; P = 0.01).



View larger version (15K):
[in this window]
[in a new window]
 
Figure 2. Comparison of the degree of Fos activation in LHRH (A) and med (B). AVPv neurons from young (filled bars) and middle-aged (open bars) rats during the LH surge. Both surge time groups are combined because they did not show significant differences from each other in either LHRH or AVPv activation. Middle-aged animals were all significantly lower than young animals, for all measures (*, P < 0.05; **, P < 0.01).

 


View larger version (18K):
[in this window]
[in a new window]
 
Figure 3. Correlation between the proportion of Fos+ LHRH neurons and the number of Fos+ medial AVPv neurons in young (open circles) and middle-aged (filled squares) killed at the time of the expected LH surge. Each symbol represents an individual animal. Intact animals whose surges were spontaneous and ovariectomized rats whose surges were induced by steroid-replacement are both included.

 
Ibotenic acid or electrolytic lesions, aimed at the AVPv, produced a wide range of lesion sizes and placements. In 4 of the rats, the medial AVPv was eliminated on 1 side of the brain. In 21 rats, no lesion was found; an equal number of animals had lesions that missed the AVPv altogether. In 3 of the animals, only a portion of the medial AVPv was destroyed by the lesion. What was quite revealing was the observation in animals with large POA lesions that either spared or eliminated the medial AVPv. Fig. 4Go shows 2 animals with ibotenic acid lesions that eliminated the majority of neurons in the rostral preoptic area on 1 side of the brain. In one (Fig. 4AGo), the medial AVPv was eliminated; in the other (Fig. 4BGo), it was spared. In the animal whose medial AVPv was destroyed, AVPv Fos activation was noted only on the intact side (Fig. 4CGo), and LHRH Fos activation was blocked on the lesioned side (Fig. 4EGo). In the other animal, Fos activation in the medial AVPv was quite normal (Fig. 4DGo), and LHRH neurons were strongly activated on both sides of the brain (Fig. 4FGo). One of the animals that received an electrolytic lesion had a bilateral lesion of the medial AVPv that extended only 100 µm from the ventricular surface (Fig. 5AGo). In that animal, LHRH neurons failed to activate on either side of the brain (Fig. 5Go, B and C). Fig. 6Go shows a summary of the plasma LH values for the animals in the lesion study. As more and more of the medial AVPv was eliminated, LH levels at the time of the expected LH surge declined; and when 1 side of the medial AVPv was completely destroyed, plasma LH was significantly lower than that of animals with no detected lesion or with lesions that missed the medial AVPv. The animals bearing partial medial AVPv lesions were intermediate. One of the electrolytically lesioned rats had a lesion placement that shifted rostrally and eliminated the majority of LHRH neurons. That animal had a plasma LH value that was lower than that in the animals with unilateral AVPv lesions and was similar to that in animals that had no LH surge.



View larger version (109K):
[in this window]
[in a new window]
 
Figure 4. A, NeuN staining of the AVPv region of the preoptic area in an animal bearing an ibotenic acid lesion that included the medial AVPv. B, NeuN staining in an animal with a lesion of the same general size as that shown in A but which spared the medial AVPv (arrows). Bar, 500 µm. C, Fos staining within the AVPv of the same animal shown in A. Note the absence of activated medial AVPv neurons ipsilateral to the lesion. D, Bilateral activation of the medial AVPv was noted in the animal depicted in B. Bar, 100 µm. E, High magnification of all the LHRH neurons surrounding the OVLT from the animal shown in A. This section was double-labeled for Fos (black) and LHRH (brown). Note that on the side of the brain ipsilateral to the complete medial AVPv lesion, most LHRH neurons failed to express Fos; whereas on the intact side, the LHRH neurons were strongly Fos-positive. F, In the animal whose medial AVPv was spared, LHRH neurons on both sides of the brain were strongly activated. Bar, 10 µm.

 


View larger version (161K):
[in this window]
[in a new window]
 
Figure 5. A, NeuN staining showing an animal with a bilateral lesion of the medial AVPv. Bar,100 µm. B, Micrograph of LHRH neurons (brown) from the left side of the brain of the same animal in a section double-labeled for Fos (black). Note that none of the LHRH neurons are Fos-positive. C, On the right side of the brain, LHRH neurons also fail to express Fos. Bar, 50 µm.

 


View larger version (17K):
[in this window]
[in a new window]
 
Figure 6. Plasma LH values from animals killed at the time of the expected LH surge. Animals were grouped according to whether they had either no lesion or missed lesions of the medial AVPv, partial medial AVPv lesions, or complete medial AVPv lesions. *, P < 0.05, compared with animals that had no/missed medial AVPv lesions. For comparison, the LH value from an animal with an electrolytic lesion destroying most of the LHRH neurons is included.

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The concept that the central nervous system and the hypothalamus, in particular, regulates the transition to reproductive acyclicity follows from studies which demonstrated that the pattern of neurochemical and neuroendocrine signals changes during middle age. It seems that these signals, which dictate the patterns of secretion of the gonadotropins, become less precise and synchronized (35). Newer data, primarily from studies performed in women during the perimenopausal period, reveal that striking parallel changes may occur in humans (36). Thus, it becomes critically important to decipher the mechanisms that regulate LHRH release and how they change with age.

Earlier studies from our laboratories, as well as those of others, indicated that the reduction in the number of LHRH neurons expressing Fos in middle-aged rats predicted the decline in peak LH values at the time of an LH surge (7, 9). The present data extend these findings and demonstrate that parallel reductions in the activation of neurons in the AVPv accompany the decline in LHRH activation that occurs during middle age. The reduction of Fos activation within both AVPv and LHRH neurons suggests that the two events are linked, either through parallel common afferents that regulate both LHRH and AVPv neuronal activity or through a sequential series of neurochemical signals. Because the AVPv neurons directly innervate LHRH neurons (15, 21), this suggests that a deficit in AVPv stimulation determines the reduction in LHRH activation. This conclusion is supported by earlier studies showing that electrolytic lesions of the entire AVPv block the LH surge (18, 19, 20, 24). Our present data (which indicate that when ibotenic acid or electrolytic lesions destroy the medial AVPv, steroid treatment fails to evoke LHRH activation on the side ipsilateral to the lesion, and LH secretion is reduced) support this hypothesis. Interestingly, lesions placed more laterally or rostrally that exclude the medial AVPv had no effect on LHRH Fos induction, further suggesting that medial AVPv is the central component. The fact that, in middle-aged rats, the LHRH neurons remain responsive to potassium stimulation to the same extent as cells from younger rats (37), further indicates that it is stimulatory drive to LHRH neurons that is reduced in aging.

What produces the reduced drive to the AVPv neurons during middle age is unknown. One possibility, based on the initial studies of cycling animals, was that E was either not secreted in sufficient amounts to trigger proper up-regulation of PRs, or that the P secretion was deficient. However, the studies of Wise and Lapolt et al. (38, 39) show that E and ER levels are maintained or elevated in middle-aged (compared with young) rats. We assayed tissue from young and middle-aged rats and found that binding of labeled P (39) and PR protein patterns (G. E. Hoffman, unpublished observation) were indistinguishable in the young and middle-aged preoptic areas. The fact that the deficit was detectable in middle-aged rats that were still regularly cycling, as well as in ovariectomized rats that received controlled concentrations of E and P, further indicates that decline in steroid levels is not the cause of reproductive failure. More likely, the declining responsiveness of AVPv neurons to other inputs is involved. One of the extrinsic factors needed for LH surges is the diurnal elevation of cAMP levels in the AVPv (40). Indeed, our preliminary data suggest that this diurnal rhythm in cAMP levels is no longer detectable in middle-aged rats (P. M. Wise, unpublished observation). Such a loss in available cAMP may render the AVPv neurons less responsive to P and prevent their ability to stimulate LHRH neurons.

Age-related alterations in activation of neurons in the AVPv are likely to have major repercussions on LHRH secretion, because an accumulating body of evidence demonstrates that the AVPv is a critical nodal relay station that integrates a host of hormonal and neuronal inputs that regulate LHRH secretion. Catecholamines, serotonin, and numerous peptide afferents terminate in this region (41). Moreover, AVPv cells contain both ER and PR (22, 42, 43). Use of either hormonal paradigms associated with surge blockade (14) or administration of transmitter receptor blockers that block LH surges (34) (G. E. Hoffman, unpublished data) block or attenuate Fos expression in the medial AVPv in parallel with blockade of LHRH Fos activation. Earlier studies, which used lesions of the entire AVPv, determined that elimination of the AVPv blocked LH surges (18, 19, 20, 24). Our data further indicate that it was the medial AVPv that produced that effect. Together, these data suggest that the AVPv functions as an integrative center for the regulation of LHRH neuron firing and that disruption of any of inputs either hormonal or neuronal, alters the drive these neurons impose on the LHRH system.

In summary, our findings demonstrate that changes in Fos activation in neurons in the AVPv occur in middle-aged proestrous and steroid-treated rats in parallel with changes in Fos activation within LHRH neurons. Lesions of the medial AVPv produce reduced LHRH activation and LH secretion. These data strongly suggest that the changes in Fos activation, during middle age, reflect altered stimulatory activity in the AVPv neurons responsible for the attenuated activity in LHRH neurons, leading to a decline in the amplitude and a delay in the onset of the LH surge that we observed previously.


    Acknowledgments
 


    Footnotes
 
This work was supported by NIH Grants NS-28730 (to G.E.H.) and AG-02224 (to P.M.W.).

Abbreviations: AVPv, Anteroventral periventricular preoptic area; DAB, diaminobenzidine HCl; E+P group, group that was administered E2 plus P; KPBS, potassium PBS; NeuN, neuron nuclear antigen; OVLT, organum vasculosum of the lamina terminalis; P, progesterone.

Received December 27, 2000.

Accepted for publication July 9, 2001.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Cooper R, Conn P, Walker R 1980 Characterization of the LH surge in middle aged female rats. Biol Reprod 23:611–615[Abstract]
  2. Meites J 1982 Alterations in proestrous LH, FSH, and prolactin surges in middle aged rats. Neuroendocrinology 34:151–156[CrossRef][Medline]
  3. Wise PM 1982 Alterations in proestrous LH, FSH, and prolactin surges in middle-aged rats. Proc Soc Exp Biol Med 169:348–354[Medline]
  4. Wise PM 1984 Estradiol-induced daily luteinizing hormone and prolactin surges in young and middle-aged rats: correlations with age-related changes in pituitary responsiveness and catecholamine turnover rates in microdissected brain areas. Endocrinology 115:801–809[Abstract]
  5. Rubin BS, Bridges RS 1989 Alterations in luteinizing hormone-releasing hormone release from the mediobasal hypothalamus of ovariectomized, steroid-primed middle-aged rats as measured by push-pull perfusion. Neuroendocrinology 49:225–232[Medline]
  6. Rubin BS, King JC 1995 A relative depletion of luteinizing hormone-releasing hormone was observed in the median eminence of young but not middle-aged rats on the evening of proestrus. Neuroendocrinology 62:259–269[CrossRef][Medline]
  7. Rubin BS, Mitchell S, Lee CE, King JC 1995 Reconstructions of populations of luteinizing hormone releasing hormone neurons in young and middle-aged rats reveal progressive increases in subgroups expressing Fos protein on proestrus and age-related deficits. Endocrinology 136:3823–3830[Abstract]
  8. Rubin B, Lee C, King J 1994 A reduced proportion of luteinizing hormone (LH)-releasing hormone neurons express Fos protein during the preovulatory or steroid-induced LH surge in middle. Biol Reprod 51:1264–1272[Abstract]
  9. Lloyd JM, Hoffman GE, Wise PM 1994 Decline in activated gonadotropin-releasing hormone (GnRH) neurons during proestrous in regularly cycling middle-aged rats. Endocrinology 134:1800–1805[Abstract]
  10. Hoffman GE, Smith MS, Verbalis JG 1993 c-Fos and related immediate early gene products as markers for neuronal activity in neuroendocrine systems. Front Neuroendocrinol 14:173–213[CrossRef][Medline]
  11. Hoffman GE, Finch CE 1986 LHRH neurons in the female C57BL/6J mouse brain during reproductive aging: no loss up to middle age. Neurobiol Aging 7:45–48[CrossRef][Medline]
  12. Funabashi T, Kimura F 1995 The number of luteinizing hormone-releasing hormone immunoreactive neurons is significantly decreased in the forebrain of old-aged female rats. Neurosci Lett 189:85–88[CrossRef][Medline]
  13. Bleier R, Byne W, Siggelkow I 1982 Cytoarchitectonic sexual dimorphisms of the medial preoptic and anterior hypothalamic areas in guinea pig, rat, hamster, and mouse. J Comp Neurol 212:118–130[CrossRef][Medline]
  14. Le WW, Attardi B, Berghorn KA, Blaustein J, Hoffman GE 1997 Progesterone blockade of a luteinizing hormone surge blocks luteinizing hormone-releasing hormone Fos activation and activation of its preoptic area afferents. Brain Res 778:272–280[CrossRef][Medline]
  15. Le WW, Berghorn K, Rassnick S, Hoffman G 1999 Periventricular preoptic area neurons coactivated with luteinizing hormone (LH)-releasing hormone (LHRH) neurons at the time of the LH surge are LHRH afferents. Endocrinology 140:510–519[Abstract/Free Full Text]
  16. Watson Jr RE, Hoffmann GE, Wiegand SJ 1986 Sexually dimorphic opioid distribution in the preoptic area: manipulation by gonadal steroids. Brain Res 398:157–163[CrossRef][Medline]
  17. Watson Jr RE, Wiegand SJ, Hoffman GE 1988 Ontogeny of a sexually dimorphic opioid system in the preoptic area of the rat. Brain Res Dev Brain Res 44:49–58[CrossRef][Medline]
  18. Wiegand SJ, Terasawa E, Bridson WE 1978 Persistent estrus and blockade of progesterone-induced LH release follows lesions which do not damage the suprachiasmatic nucleus. Endocrinology 102:1645–1648[Abstract]
  19. Wiegand SJ, Terasawa E, Bridson WE, Goy RW 1980 Effects of discrete lesions of preoptic and suprachiasmatic structures in the female rat. Alterations in the feedback regulation of gonadotropin secretion. Neuroendocrinology 31:147–157[Medline]
  20. Wiegand SJ, Terasawa E 1982 Discrete lesions reveal functional heterogeneity of suprachiasmatic structures in regulation of gonadotropin secretion in the female rat. Neuroendocrinology 34:395–404[CrossRef][Medline]
  21. Gu GB, Simerly RB 1997 Projections of the sexually dimorphic anteroventral periventricular nucleus in the female rat. J Comp Neurol 384:142–164[CrossRef][Medline]
  22. Le W, Hayashi S, Hoffman G Periventricular preoptic area neurons activated at the time of an LH surge, express both estrogen and progesterone receptors, under revision
  23. Terasawa E, Davis, GA 1983 The LHRH neuronal system in female rats: relation to the medial preoptic nucleus. Endocrinol Jpn 30:405–417[Medline]
  24. Ronnekleiv OK, Kelly MJ 1988 Plasma prolactin and luteinizing hormone profiles during the estrous cycle of the female rat: effects of surgically induced persistent estrus. Neuroendocrinology 47:133–141[Medline]
  25. Hoffman GE, Smith MS, Fitzsimmons MD 1992 Detecting steroidal effects on immediate early gene expression in the hypothalamus. Neuroprotocols 1:52–66
  26. Berghorn KA, Bonnet JH, Hoffman GE 1994 cFos immunoreactivity is enhanced with biotin amplification. J Histochem Cytochem 42:1635–1642[Abstract]
  27. Watson RE, Wiegand SJ, Clough RW, Hoffman GE 1986 Use of cryoprotectant to maintain long-term peptide immunoreactivity and tissue morphology. Peptides 7:155–159[Medline]
  28. Lee WS, Smith MS, Hoffman GE 1990 Luteinizing hormone releasing hormone (LHRH) neurons express c-Fos during the proestrous LH surge. Proc Natl Acad Sci USA 87:5163–5167[Abstract/Free Full Text]
  29. Lee WS, Smith MS, Hoffman GE 1990 Progesterone enhances the surge of luteinizing hormone by increasing the activation of luteinizing hormonereleasing hormone neurons. Endocrinology 127:2604–2606[Abstract]
  30. Lee WS, Smith MS, Hoffman GE 1992 cFos activity identifies recruitment of LHRH neurons during the ascending phase of the proestrous luteinizing hormone surge. J Neuroendocrinol 4:161–166[CrossRef]
  31. Lee WS, Smith MS, Hoffman GE 1992 LHRH neurons express cJun during the proestrous surge of luteinizing hormone. Endocrinology 130:3101–3103[Abstract]
  32. Lee WS, Abbud R, Hoffman GE, Smith MS 1993 Effects of N-methyl-D-aspartate receptor activation on cFos expression in luteinizing hormonereleasing hormone neurons in female rats. Endocrinology 133:2248–2254[Abstract]
  33. Hoffman GE, Lee WS, Attardi B, Yann V, Fitzsimmons MD 1990 LHRH neurons express c-fos after steroid activation. Endocrinology 126:1736–1741[Abstract]
  34. Le W, Berghorn K, Smith M, Hoffman G 1997 {alpha}-1 Adrenergic receptor blockade blocks LH secretion but not LHRH cFos activation. Brain Res 747:236–245[CrossRef][Medline]
  35. Wise P Aging, Reproduction and the brain. Annual Winter Conference on Brain Research, 1997 Breckinridge, CO 13:60
  36. Wise PM New understanding of the complexity of the menopause and challenges for the future. In: Bellino FL, ed. Proceedings of the international serono symposium on biology of the menopause. New York: Springer; 1–8
  37. Rubin BS 1992 Isolated hypothalami from aging female rats do not exhibit reduced basal or potassium-stimulated secretion of luteinizing hormonereleasing hormone. Biol Reprod 47:254–261[Abstract]
  38. Lapolt PS, Matt DW, Judd HL, Lu JK 1986 The relation of ovarian steroid levels in young female rats to subsequent estrous cyclicity and reproductive function during aging. Biol Reprod 35:1131–1139[Abstract]
  39. Wise PM, Parsons B 1984 Nuclear estradiol and cytosol progestin receptor concentrations in the brain and the pituitary gland and sexual behavior in ovariectomized estradiol-treated middle-aged rats. Endocrinology 115:810–816[Abstract]
  40. Chappell PE, Lee J, Levine JE 2000 Stimulation of gonadotropin-releasing hormone surges by estrogen. II. Role of cyclic adenosine 3'5'-monophosphate. Endocrinology 141:1486–1492[Abstract/Free Full Text]
  41. Simerly RB, Swanson LW 1987 The distribution of neurotransmitter-specific cells and fibers in the anteroventral periventricular nucleus: implications for the control of gonadotropin secretion in the rat. Brain Res 400:11–34[CrossRef][Medline]
  42. Warembourg M, Jolivet A, Milgrom E 1989 Immunohistochemical evidence of the presence of estrogen and progesterone receptors in the same neurons of the guinea pig hypothalamus and preoptic area. Brain Res 480:1–15[CrossRef][Medline]
  43. Blaustein JD, Turcotte JC 1989 Estradiol-induced progestin receptor immunoreactivity is found only in ER-immunoreactive cells in guinea pig brain. Neuroendocrinology 49:454–461[Medline]



This article has been cited by other articles:


Home page
EndocrinologyHome page
Y. Wang, M. Garro, H. A. Dantzler, J. A. Taylor, D. D. Kline, and M. C. Kuehl-Kovarik
Age Affects Spontaneous Activity and Depolarizing Afterpotentials in Isolated Gonadotropin-Releasing Hormone Neurons
Endocrinology, October 1, 2008; 149(10): 4938 - 4947.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
L. M. Gerhold and P. M. Wise
Vasoactive Intestinal Polypeptide Regulates Dynamic Changes in Astrocyte Morphometry: Impact on Gonadotropin-Releasing Hormone Neurons
Endocrinology, May 1, 2006; 147(5): 2197 - 2202.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
W. Yin and A. C Gore
Neuroendocrine control of reproductive aging: roles of GnRH neurons.
Reproduction, March 1, 2006; 131(3): 403 - 414.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
G. S. Neal-Perry, G. D. Zeevalk, N. F. Santoro, and A. M. Etgen
Attenuation of Preoptic Area Glutamate Release Correlates with Reduced Luteinizing Hormone Secretion in Middle-Aged Female Rats
Endocrinology, October 1, 2005; 146(10): 4331 - 4339.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
I. Merchenthaler, G. E. Hoffman, and M. V. Lane
Estrogen and Estrogen Receptor-{beta} (ER{beta})-Selective Ligands Induce Galanin Expression within Gonadotropin Hormone-Releasing Hormone-Immunoreactive Neurons in the Female Rat Brain
Endocrinology, June 1, 2005; 146(6): 2760 - 2765.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
L. M. Gerhold, K. L. Rosewell, and P. M. Wise
Suppression of Vasoactive Intestinal Polypeptide in the Suprachiasmatic Nucleus Leads to Aging-Like Alterations in cAMP Rhythms and Activation of Gonadotropin-Releasing Hormone Neurons
J. Neurosci., January 5, 2005; 25(1): 62 - 67.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
T. R. Chakraborty, G. Rajendren, and A. C. Gore
Expression of Estrogen Receptor {alpha} in the Anteroventral Periventricular Nucleus of Hypogonadal Mice
Experimental Biology and Medicine, January 1, 2005; 230(1): 49 - 56.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
H. H. Van Vugt, H. J.M. Swarts, B. J.M. Van de Heijning, and E. M. Van der Beek
Centrally Applied Somatostatin Inhibits the Estrogen-Induced Luteinizing Hormone Surge via Hypothalamic Gonadotropin-Releasing Hormone Cell Activation in Female Rats
Biol Reprod, September 1, 2004; 71(3): 813 - 819.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. R. Chakraborty, L. Ng, and A. C. Gore
Age-Related Changes in Estrogen Receptor {beta} in Rat Hypothalamus: A Quantitative Analysis
Endocrinology, September 1, 2003; 144(9): 4164 - 4171.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. R. Chakraborty, L. Ng, and A. C. Gore
Colocalization and Hormone Regulation of Estrogen Receptor {alpha} and N-Methyl-D-Aspartate Receptor in the Hypothalamus of Female Rats
Endocrinology, January 1, 2003; 144(1): 299 - 305.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Le, W.-W.
Right arrow Articles by Hoffman, G. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Le, W.-W.
Right arrow Articles by Hoffman, G. E.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Seniors' Health


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals